Evonik Venture Capital invests in HPNow
December 21, 2017. Copenhagen, Denmark – Evonik, the global specialty chemicals firm and one of the world’s largest producers of hydrogen peroxide has undertaken a minority equity investment in HPNow ApS through its corporate venture capital arm. The investment capital will be utilized to further scale up and commercialize HPNow’s disruptive on-site hydrogen peroxide generation solutions across different market sectors, where distributed on-site generation can overcome the barriers of today’s centralized hydrogen peroxide supply chain. Beyond the fresh capital, the investment provides strong endorsement to HPNow’s technology and market approach, and a strategic investor with vast experience in developing hydrogen peroxide markets. For the full Evonik press release please click here.